Poster # 1001 Use of Protoporphyrin Fluorescence to Determine Clinical Target Volume Margins for Non-Melanotic Skin Cancers Treated with Primary Radiotherapy

Presenter: Lara Best, MD

About the Presenter:
5th year Radiation Oncology resident at the London Regional Cancer Program.
Contact the presenter at:

 View the poster

E-mail a friend about this poster:
Enter email address: